Skip to main content

Advertisement

Log in

Zygomycosis Caused by Rhizopus microsporus and Rhizopus oryzae in Madhya Pradesh (M.P.) Central India: A Report of Two Cases

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Zygomycosis encompasses infections due to two distinct orders of fungi, Mucorales and Entomophthorales. With rare exception, Entomophthorales are restricted to tropical areas. By contrast, mucorales are ubiquitous opportunistic fungi, which play a crucial part in the natural decay process. In human pathology, they may be opportunistic agents and be responsible for rare infection called (Mucormycosis) zygomycosis. We report two cases of zygomycosis from Madhya Pradesh, Central India, one caused by Rhizopus oryzae in a diabetic patient and another caused by Rhizopus microsporus in an apparently healthy patient. The cases were diagnosed by direct microscopy, histopathological examination and culture. Both the patients were successfully treated with liposomal amphotericin B. Rhizopus microsporus is, for the first time reported from Madhya Pradesh, India, causing rhino-maxillary orbital zygomycosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.

    Article  PubMed  CAS  Google Scholar 

  2. Chopra H, Dua K, Bhatia S, Dua N, Mittal V. Invasive rhino-orbital fungal sinusitis following dental manipulation. Mycoses. 2008;52:368–71.

    Article  PubMed  Google Scholar 

  3. Kwon-Chung KJ, Bennett JE. Medical mycology. Philadelphia: Lea and Febiger; 1992.

    Google Scholar 

  4. Gonzalez CE, Courier DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with Amphotericin B lipid complex and granulocyte colony stimulating factor. Clin Infect Dis. 1997;24:192–6.

    Article  PubMed  CAS  Google Scholar 

  5. Gonzalez CE, Rinaldi M, Sugar A. Zygomycosis infectious disease. Clin N Am. 2002;16:117–25.

    Google Scholar 

  6. Vyzantiadis TA, Kioumi A, Papadakis E, Braimi M, Dermitzakis E, Tsitouridis L, Antoniadis A. Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report. Mycoses. 2008;52:87–90.

    Article  PubMed  Google Scholar 

  7. Rodriquez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J, et al. On behalf of the Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008;14:982–4.

    Google Scholar 

  8. Diwakar A, Dewan RK, Chowdhary A, Randhawa HS, Khanna G, Gaur SN. Zygomycosis—a case report and overview of the disease in India. Mycoses. 2007;50:247–54.

    Article  PubMed  Google Scholar 

  9. Tiwari S, Singh SM, Naidu J, Nawange SR, Dhindsa MK, Jain S, Chawla A. Rhino-maxillary-orbital dual infection caused by Rhizopus oryzae and Alternaria spp. in a child suffering from jaundice (Hepatitis A): a case report and successful chemotherapy. Mycol Med 2001;11(3):166–70.

    Google Scholar 

  10. Chakrabarti A, Das A, Sharma A, Panda N, Das S, Gupta KL, Sakhuja V. Ten year’s experience in zygomycosis at a tertiary care centre in India. J Infect. 2001;42:261–6.

    Article  PubMed  CAS  Google Scholar 

  11. Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44:335–42.

    Article  PubMed  Google Scholar 

  12. Ainsworth GC. The pattern of medical and veterinary mycological information. Sabouraudia. 1966;5:81–6.

    Article  PubMed  CAS  Google Scholar 

  13. Alvarez E, Sutten DA, Cano J, Fothergill AW, Stchigel A, Rinaldi MG, Guarro J. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol. 2009;47:1650–6.

    Article  PubMed  CAS  Google Scholar 

  14. Rao SP, Kumar KR, Rokade VR, Khanna V, Pal C. Orbital apex syndrome due to mucormycosis caused by Rhizopus microsporus. Indian J Otolaryngeol Head neck Surg. 2006;58:84–7.

    Google Scholar 

  15. Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, Varma SC, Singhi S, Bhansali A, Sakhuja V. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J. 2009;85:573–81.

    Article  PubMed  CAS  Google Scholar 

  16. Boelaert JR. Mucormycosis (zygomycosis): is there news for the clinician? J Infect. 1994;28:1–6.

    Article  PubMed  Google Scholar 

  17. Sica S, Morace G, LaRocca LM, Etuk B, Di Marro A, Pagano L, Zini G, Rutella S, Leone G. Rhinocerebral zygomycosis in acute lymphoblastic leukemia. Mycoses. 1993;36:289–91.

    Article  PubMed  CAS  Google Scholar 

  18. Van Burik JA, Hare RS, Solomon HE, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a Retrospective summary of 91 cases. Clin Infect Dis. 2006;42:61–5.

    Article  Google Scholar 

  19. Greenberg RN, Mullane K, Van Burik JA, Raad, H, Abzug I, Anstead MJ, Herbrecht G, Langston RA, Marr KA, Schiller G, Schuster M, Wingard MJ, Gonzalez CE, Revankar SG, CorcoranG, Kryscio RJ, Hare R. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50:126–33.

  20. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 2007;51:2587–90.

    Article  PubMed  CAS  Google Scholar 

  21. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of Filamentous fungi: approved standard M38-A. Wayne: NCCLS; 2002.

    Google Scholar 

  22. Sabatelli F, Patel R, Mann PA, et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother. 2006;50:2009–15.

    Article  PubMed  CAS  Google Scholar 

  23. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004;42:4419–31.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank the Vice-Chancellor Rani Durgavati. University, for providing laboratory facilities and to The Director-General, Indian Council of Medical Research (ICMR), New Delhi, for awarding Research Associate Fellowship and Post Doctoral Research Associateship and Government of India, Ministry of Science and Technology, Department of Science and Technology SERC FAST Track Scheme, for Young Scientist to one of the author (S.R.N).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. M. Singh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nawange, S.R., Singh, S.M., Naidu, J. et al. Zygomycosis Caused by Rhizopus microsporus and Rhizopus oryzae in Madhya Pradesh (M.P.) Central India: A Report of Two Cases. Mycopathologia 174, 171–176 (2012). https://doi.org/10.1007/s11046-012-9532-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-012-9532-0

Keywords

Navigation